Groupama Asset Managment »

Cytokinetics shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Cytokinetics shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 1.2M 1.41

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Amazon (AMZN)
Agnico (AEM)
Motorola Solutions Com New (MSI)
Thermo Fisher Scientific (TMO)
Parker-Hannifin Corporation (PH)
Wal-Mart Stores (WMT)
Meta Platforms Cl A (META)
Boston Scientific Corporation (BSX)

View all positions for Groupama Asset Managment

Top funds holding Cytokinetics

FMR
Balyasny Asset Management
Wellington Management Company
Lazard Asset Management
Capstone Investment Advisors
Leucadia National Corporation
Goldman Sachs Group
Bnp Paribas Investment Partners
Advent Capital Management
AXA Investment Managers
Context Capital Management
Groupama Asset Managment
Jpmorgan Chase & Co
Jane Street
Shenkman Capital Management

View all funds holding Cytokinetics